Developmental Cardiotoxicity and Hepatotoxicity of Flurbiprofen Axetil to Zebrafish Embryo-Reference-Cited by-同舟云学术

Developmental Cardiotoxicity and Hepatotoxicity of Flurbiprofen Axetil to Zebrafish Embryo

Published:2022-04-01 Issue:3 Volume:20 Page:125-135
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Wang Yuping¹,Zhou Min¹,Wang Jing¹,Lin Chuantao¹,Gao Xiang¹,Zhang Li¹,Yao Wenshui¹,Zhang Longxin¹^ORCID

Affiliation:

1. Department of Anesthesiology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/adt.2021.127

Reference41 articles.

1. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials

2. The zebrafish reference genome sequence and its relationship to the human genome

3. Zebrafish Embryos and Larvae as Alternative Animal Models for Toxicity Testing

4. Preoperative flurbiprofen axetil administration for acute postoperative pain: a meta-analysis of randomized controlled trials

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiral S-flurbiprofen axetil-loaded lipid microspheres for improved analgesic effects: Preparation, characterization, and preclinical evaluation;Journal of Drug Delivery Science and Technology;2024-02

2. Incorporating Primer Amplification Efficiencies in Quantitative Reverse Transcription Polymerase Chain Reaction Experiments; Considerations for Differential Gene Expression Analyses in Zebrafish;Zebrafish;2023-10-01